Concepts (226)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Transplantation | 18 | 2012 | 207 | 3.030 |
Why?
|
| Pandemics | 3 | 2020 | 618 | 1.450 |
Why?
|
| Living Donors | 15 | 2012 | 75 | 1.430 |
Why?
|
| Jehovah's Witnesses | 7 | 2006 | 17 | 1.290 |
Why?
|
| Blood Transfusion | 6 | 2007 | 150 | 1.190 |
Why?
|
| Hepatectomy | 7 | 2016 | 62 | 1.180 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 193 | 1.090 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 206 | 1.080 |
Why?
|
| Liver Neoplasms | 4 | 2016 | 277 | 0.810 |
Why?
|
| Hospitals, Community | 1 | 2022 | 69 | 0.790 |
Why?
|
| Religion and Medicine | 4 | 2005 | 17 | 0.760 |
Why?
|
| Trauma Centers | 1 | 2022 | 114 | 0.750 |
Why?
|
| Pancreatic Neoplasms | 4 | 2015 | 332 | 0.700 |
Why?
|
| Graft Survival | 10 | 2012 | 290 | 0.690 |
Why?
|
| Health Care Rationing | 1 | 2020 | 21 | 0.680 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 14 | 0.680 |
Why?
|
| Government Regulation | 1 | 2020 | 40 | 0.670 |
Why?
|
| Appendicitis | 1 | 2020 | 78 | 0.650 |
Why?
|
| Perioperative Care | 1 | 2020 | 76 | 0.640 |
Why?
|
| Infection Control | 1 | 2020 | 96 | 0.620 |
Why?
|
| Surgical Procedures, Operative | 1 | 2020 | 137 | 0.610 |
Why?
|
| Health Policy | 1 | 2020 | 177 | 0.600 |
Why?
|
| Health Care Costs | 1 | 2020 | 202 | 0.590 |
Why?
|
| Betacoronavirus | 1 | 2020 | 167 | 0.590 |
Why?
|
| Tissue and Organ Procurement | 5 | 2012 | 38 | 0.570 |
Why?
|
| Tissue Donors | 4 | 2012 | 147 | 0.570 |
Why?
|
| Pancreaticoduodenectomy | 2 | 2015 | 63 | 0.570 |
Why?
|
| Endoscopy, Digestive System | 2 | 2015 | 25 | 0.560 |
Why?
|
| General Surgery | 1 | 2020 | 194 | 0.560 |
Why?
|
| Pancreatectomy | 2 | 2015 | 97 | 0.530 |
Why?
|
| Hyperthermia, Induced | 1 | 2016 | 18 | 0.520 |
Why?
|
| Peritoneal Neoplasms | 1 | 2016 | 25 | 0.520 |
Why?
|
| Splenectomy | 2 | 2014 | 41 | 0.510 |
Why?
|
| Retrospective Studies | 13 | 2022 | 6156 | 0.500 |
Why?
|
| Pancreatic Ducts | 1 | 2015 | 30 | 0.490 |
Why?
|
| Intraoperative Care | 1 | 2015 | 36 | 0.480 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 527 | 0.480 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2014 | 15 | 0.460 |
Why?
|
| Blood Platelets | 1 | 2014 | 92 | 0.430 |
Why?
|
| Colorectal Neoplasms | 1 | 2016 | 263 | 0.420 |
Why?
|
| Humans | 41 | 2022 | 59744 | 0.400 |
Why?
|
| Duodenum | 2 | 2021 | 42 | 0.400 |
Why?
|
| Middle Aged | 22 | 2022 | 16452 | 0.400 |
Why?
|
| Donor Selection | 2 | 2012 | 16 | 0.370 |
Why?
|
| Male | 27 | 2020 | 27952 | 0.370 |
Why?
|
| Treatment Outcome | 14 | 2014 | 5334 | 0.360 |
Why?
|
| Cholestasis | 2 | 2008 | 54 | 0.360 |
Why?
|
| Hospitals, Religious | 1 | 2010 | 2 | 0.350 |
Why?
|
| Follow-Up Studies | 7 | 2016 | 2354 | 0.350 |
Why?
|
| Aged | 14 | 2022 | 13513 | 0.350 |
Why?
|
| Female | 27 | 2021 | 30926 | 0.350 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2009 | 167 | 0.340 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 2 | 2008 | 46 | 0.340 |
Why?
|
| Organ Transplantation | 1 | 2010 | 53 | 0.330 |
Why?
|
| Aneurysm, False | 2 | 2012 | 46 | 0.310 |
Why?
|
| Blood Transfusion, Autologous | 2 | 2005 | 6 | 0.310 |
Why?
|
| Biliary Tract | 1 | 2008 | 7 | 0.300 |
Why?
|
| Adult | 16 | 2020 | 15771 | 0.300 |
Why?
|
| Adenocarcinoma | 3 | 2021 | 327 | 0.280 |
Why?
|
| Aged, 80 and over | 7 | 2022 | 5150 | 0.270 |
Why?
|
| Liver Diseases | 2 | 2005 | 138 | 0.270 |
Why?
|
| Adolescent | 7 | 2020 | 5866 | 0.260 |
Why?
|
| Hepatic Veins | 1 | 2006 | 13 | 0.250 |
Why?
|
| Foreign-Body Reaction | 1 | 2005 | 15 | 0.250 |
Why?
|
| Iliac Artery | 1 | 2006 | 49 | 0.250 |
Why?
|
| United States | 8 | 2020 | 7448 | 0.250 |
Why?
|
| Risk Factors | 8 | 2014 | 5011 | 0.240 |
Why?
|
| Coagulants | 1 | 2005 | 2 | 0.240 |
Why?
|
| Factor VIIa | 1 | 2005 | 3 | 0.240 |
Why?
|
| Amyloidosis | 1 | 2006 | 62 | 0.240 |
Why?
|
| Young Adult | 5 | 2020 | 4290 | 0.240 |
Why?
|
| Hemodilution | 4 | 2005 | 11 | 0.240 |
Why?
|
| Postoperative Care | 4 | 2006 | 117 | 0.230 |
Why?
|
| Massachusetts | 2 | 2020 | 2027 | 0.230 |
Why?
|
| Pancreas | 2 | 2004 | 146 | 0.230 |
Why?
|
| Postoperative Complications | 4 | 2016 | 1217 | 0.220 |
Why?
|
| Stents | 1 | 2008 | 468 | 0.220 |
Why?
|
| Portasystemic Shunt, Surgical | 1 | 2003 | 3 | 0.220 |
Why?
|
| Stomach | 1 | 2004 | 83 | 0.220 |
Why?
|
| Splenic Artery | 1 | 2003 | 9 | 0.220 |
Why?
|
| Hypertension, Portal | 1 | 2003 | 14 | 0.220 |
Why?
|
| Emergency Service, Hospital | 2 | 2022 | 1024 | 0.220 |
Why?
|
| Portal Vein | 1 | 2003 | 38 | 0.220 |
Why?
|
| Patient Care Team | 2 | 2020 | 330 | 0.210 |
Why?
|
| Aneurysm | 1 | 2003 | 57 | 0.210 |
Why?
|
| Survival Rate | 3 | 2016 | 804 | 0.200 |
Why?
|
| Echinococcosis, Hepatic | 1 | 2002 | 5 | 0.200 |
Why?
|
| Incidence | 2 | 2020 | 1245 | 0.200 |
Why?
|
| Vena Cava, Inferior | 2 | 2017 | 30 | 0.200 |
Why?
|
| Cadaver | 4 | 2006 | 114 | 0.200 |
Why?
|
| Blood Loss, Surgical | 4 | 2006 | 59 | 0.190 |
Why?
|
| Catheter Ablation | 2 | 2016 | 149 | 0.190 |
Why?
|
| Watchful Waiting | 1 | 2021 | 25 | 0.180 |
Why?
|
| Gangrene | 1 | 2020 | 7 | 0.180 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2021 | 32 | 0.180 |
Why?
|
| Time Factors | 7 | 2012 | 3629 | 0.170 |
Why?
|
| Feasibility Studies | 1 | 2022 | 531 | 0.170 |
Why?
|
| Liver Cirrhosis | 3 | 2009 | 164 | 0.170 |
Why?
|
| Appendectomy | 1 | 2020 | 52 | 0.170 |
Why?
|
| Geriatric Assessment | 1 | 2021 | 158 | 0.170 |
Why?
|
| Time-to-Treatment | 1 | 2020 | 98 | 0.160 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2014 | 1541 | 0.160 |
Why?
|
| Emergencies | 1 | 2020 | 111 | 0.160 |
Why?
|
| Pilot Projects | 1 | 2022 | 922 | 0.160 |
Why?
|
| Reoperation | 3 | 2012 | 275 | 0.160 |
Why?
|
| Referral and Consultation | 1 | 2022 | 405 | 0.160 |
Why?
|
| Clinical Protocols | 1 | 2020 | 137 | 0.160 |
Why?
|
| Chi-Square Distribution | 4 | 2012 | 409 | 0.150 |
Why?
|
| Constriction, Pathologic | 2 | 2008 | 114 | 0.140 |
Why?
|
| Liver | 3 | 2008 | 798 | 0.140 |
Why?
|
| Abdominal Neoplasms | 1 | 2017 | 17 | 0.140 |
Why?
|
| Peritoneum | 1 | 2017 | 30 | 0.140 |
Why?
|
| Infusions, Parenteral | 1 | 2016 | 21 | 0.130 |
Why?
|
| Organoplatinum Compounds | 1 | 2016 | 17 | 0.130 |
Why?
|
| Cytoreduction Surgical Procedures | 1 | 2016 | 8 | 0.130 |
Why?
|
| Mitomycin | 1 | 2016 | 26 | 0.130 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2016 | 33 | 0.130 |
Why?
|
| Anastomosis, Surgical | 2 | 2008 | 109 | 0.130 |
Why?
|
| Disease-Free Survival | 1 | 2016 | 229 | 0.130 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 357 | 0.120 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2012 | 402 | 0.120 |
Why?
|
| Preoperative Care | 3 | 2007 | 182 | 0.120 |
Why?
|
| Liver Circulation | 2 | 2006 | 11 | 0.120 |
Why?
|
| Choledochal Cyst | 1 | 2014 | 3 | 0.120 |
Why?
|
| Length of Stay | 4 | 2014 | 790 | 0.120 |
Why?
|
| Risk Assessment | 4 | 2012 | 1935 | 0.120 |
Why?
|
| Liver Failure | 2 | 2005 | 17 | 0.120 |
Why?
|
| Nephrectomy | 2 | 2007 | 78 | 0.120 |
Why?
|
| Platelet Count | 1 | 2014 | 25 | 0.120 |
Why?
|
| Graft Rejection | 2 | 2007 | 291 | 0.120 |
Why?
|
| Algorithms | 1 | 2020 | 981 | 0.120 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2014 | 48 | 0.110 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2014 | 103 | 0.110 |
Why?
|
| Databases as Topic | 2 | 2011 | 52 | 0.110 |
Why?
|
| Biopsy | 1 | 2015 | 420 | 0.110 |
Why?
|
| Bone Marrow | 1 | 2014 | 174 | 0.110 |
Why?
|
| Kidney Transplantation | 2 | 2007 | 318 | 0.100 |
Why?
|
| Vascular Patency | 2 | 2017 | 138 | 0.090 |
Why?
|
| Health Resources | 1 | 2012 | 88 | 0.090 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2012 | 77 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 633 | 0.090 |
Why?
|
| Oklahoma | 1 | 2010 | 6 | 0.090 |
Why?
|
| Embolization, Therapeutic | 2 | 2004 | 310 | 0.090 |
Why?
|
| Total Quality Management | 1 | 2010 | 56 | 0.090 |
Why?
|
| Academic Medical Centers | 1 | 2012 | 311 | 0.080 |
Why?
|
| Transplantation, Homologous | 1 | 2010 | 244 | 0.080 |
Why?
|
| Models, Organizational | 1 | 2010 | 92 | 0.080 |
Why?
|
| alpha-Fetoproteins | 1 | 2009 | 15 | 0.080 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 2009 | 11 | 0.080 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 2009 | 19 | 0.080 |
Why?
|
| Hepatitis B | 1 | 2009 | 29 | 0.080 |
Why?
|
| Quality Indicators, Health Care | 1 | 2012 | 333 | 0.080 |
Why?
|
| Cause of Death | 2 | 2012 | 210 | 0.080 |
Why?
|
| Continuity of Patient Care | 1 | 2010 | 170 | 0.080 |
Why?
|
| Hepatic Duct, Common | 1 | 2008 | 7 | 0.080 |
Why?
|
| Global Health | 1 | 2009 | 168 | 0.080 |
Why?
|
| Cholangiography | 1 | 2008 | 42 | 0.070 |
Why?
|
| Bile Ducts | 1 | 2008 | 21 | 0.070 |
Why?
|
| Program Evaluation | 1 | 2010 | 471 | 0.070 |
Why?
|
| Hepatitis C | 1 | 2009 | 143 | 0.070 |
Why?
|
| Catheterization | 1 | 2008 | 111 | 0.070 |
Why?
|
| Child, Preschool | 3 | 2014 | 1802 | 0.070 |
Why?
|
| Endoscopy | 1 | 2008 | 104 | 0.070 |
Why?
|
| Risk | 1 | 2008 | 368 | 0.070 |
Why?
|
| CA-19-9 Antigen | 1 | 2007 | 10 | 0.070 |
Why?
|
| Xanthomatosis | 1 | 2007 | 8 | 0.070 |
Why?
|
| Jejunal Neoplasms | 1 | 2007 | 4 | 0.070 |
Why?
|
| Cholecystitis | 1 | 2007 | 27 | 0.070 |
Why?
|
| Granuloma | 1 | 2007 | 41 | 0.070 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2007 | 15 | 0.070 |
Why?
|
| Equipment Design | 1 | 2008 | 334 | 0.070 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2007 | 19 | 0.070 |
Why?
|
| Celiac Artery | 1 | 2006 | 14 | 0.070 |
Why?
|
| Death | 1 | 2006 | 25 | 0.070 |
Why?
|
| Image Enhancement | 1 | 2008 | 189 | 0.070 |
Why?
|
| Age Factors | 1 | 2010 | 1511 | 0.060 |
Why?
|
| Liver Regeneration | 1 | 2006 | 18 | 0.060 |
Why?
|
| Laparotomy | 1 | 2005 | 49 | 0.060 |
Why?
|
| Erythropoietin | 1 | 2005 | 35 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 1104 | 0.060 |
Why?
|
| Blood Volume | 1 | 2005 | 42 | 0.060 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2004 | 25 | 0.060 |
Why?
|
| Probability | 1 | 2004 | 170 | 0.060 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2004 | 12 | 0.050 |
Why?
|
| Hematocrit | 1 | 2004 | 32 | 0.050 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 2005 | 62 | 0.050 |
Why?
|
| Biopsy, Needle | 1 | 2004 | 135 | 0.050 |
Why?
|
| Reference Values | 1 | 2004 | 330 | 0.050 |
Why?
|
| Blood Component Transfusion | 1 | 2003 | 8 | 0.050 |
Why?
|
| Anemia | 1 | 2005 | 119 | 0.050 |
Why?
|
| Biomarkers, Tumor | 1 | 2007 | 466 | 0.050 |
Why?
|
| Plasma | 1 | 2003 | 35 | 0.050 |
Why?
|
| Albendazole | 1 | 2002 | 9 | 0.050 |
Why?
|
| APACHE | 1 | 2002 | 48 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 691 | 0.050 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2003 | 179 | 0.050 |
Why?
|
| Decompression, Surgical | 1 | 2002 | 61 | 0.050 |
Why?
|
| Anthelmintics | 1 | 2002 | 42 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 2 | 2017 | 262 | 0.050 |
Why?
|
| Drainage | 1 | 2002 | 151 | 0.050 |
Why?
|
| Pancreatitis | 1 | 2002 | 95 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2004 | 1061 | 0.050 |
Why?
|
| Patient Admission | 1 | 2002 | 185 | 0.040 |
Why?
|
| Infant | 1 | 2005 | 1496 | 0.040 |
Why?
|
| Advance Care Planning | 1 | 2021 | 61 | 0.040 |
Why?
|
| Proportional Hazards Models | 2 | 2012 | 674 | 0.040 |
Why?
|
| Laparoscopy | 1 | 2003 | 450 | 0.040 |
Why?
|
| Transplantation, Autologous | 1 | 2017 | 120 | 0.030 |
Why?
|
| Operative Time | 1 | 2014 | 84 | 0.030 |
Why?
|
| Hospital Costs | 1 | 2012 | 121 | 0.020 |
Why?
|
| Child | 2 | 2014 | 4215 | 0.020 |
Why?
|
| Radiography | 1 | 2012 | 519 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 909 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2012 | 818 | 0.020 |
Why?
|
| Registries | 1 | 2012 | 805 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2012 | 435 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2012 | 850 | 0.020 |
Why?
|
| Cholecystectomy | 1 | 2007 | 31 | 0.020 |
Why?
|
| Treatment Refusal | 1 | 2007 | 54 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2007 | 943 | 0.010 |
Why?
|
| Multiple Organ Failure | 1 | 2002 | 43 | 0.010 |
Why?
|
| Pain, Postoperative | 1 | 2003 | 146 | 0.010 |
Why?
|
| Necrosis | 1 | 2002 | 140 | 0.010 |
Why?
|
| Acute Disease | 1 | 2002 | 660 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2003 | 837 | 0.010 |
Why?
|
| Prognosis | 1 | 2002 | 1613 | 0.010 |
Why?
|